Unione Europea - ungherese - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunszuppresszánsok - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris limited - doxazosina mesilato - comprimido - 4 mg - doxazosina mesilato 4 mg - doxazosina

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris limited - drospirenona; etinilestradiol - comprimido recubierto con pelÍcula - 3 mg/0,02 mg - drospirenona 3 mg; etinilestradiol 0,02 mg - drospirenona y estrógeno

Unione Europea - italiano - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosoppressori - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Unione Europea - finlandese - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - diabeetilla käytettävät lääkkeet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Unione Europea - slovacco - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresíva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals s.l.u. - metamizol magnesico - cÁpsula dura - 575 mg - metamizol magnesico 575 mg - metamizol sódico

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals s.l.u. - apixaban - comprimido recubierto con pelÍcula - 5 mg - apixaban 5 mg - apixabán

Unione Europea - lituano - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresantai - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals s.l.u. - apixaban - comprimido recubierto con pelÍcula - 2,5 mg - apixaban 2,5 mg - apixabán